Mapping dopamine receptors in the human brain

  • J. M. Palacios
  • M. Camps
  • R. Cortés
  • A. Probst
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 27)


We have investigated the anatomic localization of dopamine D1 and D2 receptors in the human brain using selective high affinity ligands for both types of dopamine receptors and the technique of receptor autoradiography. Dopamine D1 receptors were labeled in postmortem human brain tissue sections using the antagonist [3H]SCH 23390. Dopamine D2 receptors were labeled in consecutive tissue sections using the agonist [3H]205-502 and the antagonist [3H]spiroperidol. D1 and D2 dopamine receptors presented a heterogeneous distribution in the human brain. The highest concentrations of both D1 and D2 receptors were found in parts of the basal ganglia, particularly the nucleus caudatus and putamen. Lower concentrations were seen in other areas for example, the lateral globus pallidus was enriched in D2 receptors and the medial globus pallidus in D1 receptors. The substantia nigra contained intermediate densities of both D1 and D2, D1 receptors being present in higher concentrations. Dopamine D1 receptors were also localized in areas outside of the basal ganglia, particularly in the neocortex, amygdala and hippocampal formation. Dopamine D2 receptors were also present in areas outside of the basal ganglia, the most significant densities being found in the hippocampal formation. We observed a marked age-dependent decline in the density of D1 receptors during the first decades of life. In contrast, D2 receptor concentrations appeared to be unaltered with age. The distribution and densities of dopamine receptors were examined in 12 cases of Parkinson’s disease and compared to a control adult population. No significant differences in density and distribution were seen for either D1 nor D2 receptors.


Dopamine Receptor Globus Pallidus Progressive Supranuclear Palsy Olfactory Tubercle Postmortem Delay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baron JB, Comar D, Zarifian E, Agid Y, Crouzel C, Loo H, Deniker P, Kellershohn C (1984) Dopaminergic receptor sites in human brain: positron emission tomography. Neurology 35: 16–24CrossRefGoogle Scholar
  2. Baron JC, Maziere B, Loch C, Sgouropoulos P, Bonnet AM, Agid Y (1985) Progressive supranuclear palsy; Loss of striatal dopamine receptors demonstrated in vivo by positron emission tomography. Lancet 1: 1163–1164PubMedCrossRefGoogle Scholar
  3. Bird ED, Iversen LL (1982) Human brain postmortem studies of neurotransmitter and related markers. In: Lajtha A (ed) Handbook of neurochemistry, vol 2. Plenum Press, pp 225–251Google Scholar
  4. Bogerts B (1981) A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker. J Comp Neurol 197: 63–80PubMedCrossRefGoogle Scholar
  5. Camps M, Cortés R, Zürcher B, Probst A, Palacios JM (1987) Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Submitted Carlsson A, Lindquist J (1963) Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140–144Google Scholar
  6. Charuchinda C, Supavilai P, Karobath M, Palacios JM (1987) Dopamine D2 receptors in rat brain: autoradiographic visualization using a high affinity selective agonist ligand. J Neurosci 7: 1352–1360PubMedGoogle Scholar
  7. Cortés R, Probst A, Palacios JM (1984) Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in human brain: brainstem. Neuroscience 12: 1003–1026PubMedCrossRefGoogle Scholar
  8. Cortés R, Zürcher B, Pazos A, Probst A, Palacios JM (1987) Dopamine receptors in human brain: autoradiographic distribution of D] sites. Submitted Crow TJ, Johnstone EC, Owen F (1979) Research on schizophrenia. Recent Adv Clin Psychiatry 3: 1–35Google Scholar
  9. Dawson TM, Gehlert DR, McCabe RT, Barnett A, Wamsley JK (1986) D, dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J Neurosci 6: 2352–2365PubMedGoogle Scholar
  10. Farde L, Hall H, Ehrin E, Seduall G (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231: 258–261PubMedCrossRefGoogle Scholar
  11. Friedmann AM, Dejesus OT, Woolverton WL, van Moffaert G, Goldberg LI, Prasad A, Barnett A, Dinerstein J (1985) Positron tomography of a radiobrominated analogue of the D1/D2 antagonist SCH 23390. Eur J Pharmacol 108: 327–328CrossRefGoogle Scholar
  12. Gehlert DR, Wamsley JK (1985) Dopamine receptors in the rat brain: quantitative autoradiographic localization using [3H]sulpiride. Neurochem Int 7: 717–723PubMedCrossRefGoogle Scholar
  13. Hornykiewicz O (1972) Dopamine and its physiological significance in brain function. In: Bourne GH (ed) The structure and function of nervous systems, vol 6. Academic Press, New York, pp 367–415Google Scholar
  14. Kebabian SW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93–96PubMedCrossRefGoogle Scholar
  15. Kuhar MJ (1985) The mismatch problem in receptor mapping studies. Trends Neurosci 8: 190–191CrossRefGoogle Scholar
  16. Lee T, Seeman P, Rajput A, Parley I J, Hornykiewicz O (1978) Receptor basis for dopaminergic supersensitivity in Parkinson’s disease. Nature 273: 59–60PubMedCrossRefGoogle Scholar
  17. McGeer PL, McGeer EG, Suzuki JS (1977) Aging and extrapyramidal function. Arch Neurol 34: 33–35PubMedCrossRefGoogle Scholar
  18. Owen F, Crow TJ, Poulter M, Cross AJ, Longden A, Riley GJ (1978) Increased dopamine receptor sensitivity in schizophrenia. Lancet 2: 223–225PubMedCrossRefGoogle Scholar
  19. Palacios JM, Pazos A (1987) Visualization of dopamine receptors: a progress review. In: Creese I, Frazer C (eds) Structure and function of dopamine receptors. Alan R Liss, New York, in pressGoogle Scholar
  20. Palacios JM, Probst A, Cortés R (1986) Mapping receptors in the human brain. Trends Neurosci 9: 284–289CrossRefGoogle Scholar
  21. Pimoule C, Schoemaker H, Reynolds GP, Langer SZ (1985) [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson’s disease. Eur J Pharmacol 114: 235–237Google Scholar
  22. Raisman R, Cash R, Ruberg M, Javoy-Agid F, Agid Y (1985) Binding of [3H]SCH 23390 to D1 receptors in the putamen of control and parkinsonian subjects. Eur J Pharmacol 113: 467–468PubMedCrossRefGoogle Scholar
  23. Rinne UK, Koskinen V, Lönnberg P (1980) Neurotransmitter receptor in parkinsonian brain. In: Rinne UK, Klinger M, Stamm G (eds) Parkinson’s disease — current progress, problems, and management, vol 6. Elsevier North Holland Biochemical Press, New York, pp 93–107Google Scholar
  24. Ruberg M, Javoy-Agid F, Hirsch E, Scatton B, Lheureux R, Hauw JJ, Doyckaerts C, Gray F, Morel-Maroger A, Rascol A, Serdaru M, Agid I (1985) Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol 18: 523–529PubMedCrossRefGoogle Scholar
  25. Savasta M, Dubois A, Scatton B (1986 a) Autoradiographic localization of Dx dopamine receptors in the rat brain using [3H]SCH 23390. Brain Res 375: 291–301Google Scholar
  26. Savasta M, Dubois A, Benavides J, Scatton B (1986 b) Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat. Neurosci Lett 72: 265–271Google Scholar
  27. Scatton B, d’Ambrosio A, Javoy-Agid F, Agid Y, Bischoff S, Simon H, le Moal M (1982) Evidence for the existence of a dopaminergic innervation of the rat and human hippocampal formation. In: Koshaka M, Shohmori T, Tsukada Y, Woodruff GN (eds) Advances in dopamine research. Pergamon Press, Oxford, pp 337–382Google Scholar
  28. Schwartz R, Creese I, Coyle JT, Snyder SH (1978) Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature 271: 766–768CrossRefGoogle Scholar
  29. Spano PF, Govoni S, Trabucchi M (1977 a) Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol 16: 307–310Google Scholar
  30. Spano PF, Trabucchi M, di Chiara G (1977 b) Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum. Science 196: 1343–1345Google Scholar
  31. Stoof JC, Kebabian JW (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sei 35: 2281–2296CrossRefGoogle Scholar
  32. Unnerstall JR, Niehoff DL, Kuhar MJ, Palacios JM (1982) Quantitative receptor autoradiography using [3H]Ultrofilm: application to multiple benzodiazepine receptors. J Neurosci Methods 6: 59–73PubMedCrossRefGoogle Scholar
  33. Wagner HN, Burns HD, Dannais RF, Wong DF, Langström B, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SB, Lukas SE, Kramer AY, Kuhar MJ (1983) Imaging dopamine receptors in the human brain by positron emission tomography. Science 221: 1264–1266PubMedCrossRefGoogle Scholar
  34. Wong DF, Wagner HN, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE, Gjedde A, Douglas KH, Petronis JD, Folstein MF, Toung JKT, Burns HD, Kuhar MJ (1984) Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science 226: 1393–1396PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • J. M. Palacios
    • 1
  • M. Camps
    • 1
    • 3
  • R. Cortés
    • 1
  • A. Probst
    • 2
  1. 1.Preclinical ResearchSandoz Ltd.BasleSwitzerland
  2. 2.Department of Neuropathology, Institute of PathologyUniversity of BasleBasleSwitzerland
  3. 3.Department of Biochemistry, School of MedicineUniversity of BarcelonaBarcelonaSpain

Personalised recommendations